The Ripple Effect: How RFK Jr.'s Vaccine Agenda Is Reshaping Global Health — and Costing Lives

In June 2025, Robert F. Kennedy Jr. fired every member of the Advisory Committee on Immunization Practices, the panel of scientists that had shaped U.S. vaccine policy for decades. It was not an isolated act. It was the opening salvo in a systematic campaign that has now redrawn the global landscape of immunization — dismantling domestic safeguards, severing international funding pipelines, and, according to mounting evidence, contributing to a worldwide resurgence of diseases that modern medicine had nearly conquered.

The fallout extends far beyond American borders. From measles wards in Texas to meningitis outbreaks across sub-Saharan Africa, the consequences of Kennedy's tenure as Secretary of Health and Human Services are being measured in hospitalizations, in funding gaps worth billions, and — increasingly — in lives lost.

Dismantling the Domestic Architecture

Kennedy's overhaul of U.S. vaccine policy began almost immediately after his Senate confirmation. In May 2025, he overrode the Advisory Committee on Immunization Practices' recommendation on COVID-19 vaccination for pregnant women and young children [1]. The following month, he dismissed all 17 members of the committee itself, citing alleged conflicts of interest that the Infectious Diseases Society of America called "completely unfounded" [2].

The move was unprecedented. ACIP's recommendations had long served as the gold standard for determining which vaccines insurers would cover, which shots providers would recommend, and what the public could expect from the nation's immunization infrastructure [3]. Without a functioning committee, that architecture began to crack. Provider organizations started issuing their own guidance. Insurance coverage for certain vaccines became uncertain. And vaccine manufacturers began questioning whether the U.S. market was worth the regulatory risk [3].

Kennedy then directed the CDC to change the designation for six vaccines on the federal schedule, downgrading them from routine recommendations for children [4]. The number of pediatric vaccines presented in federal guidance dropped from 17 to roughly 11 [1]. He hired David Geier, a known vaccine skeptic with a revoked medical license, to lead a study reinvestigating the long-discredited theory that vaccines cause autism [4].

In August 2025, Kennedy announced the cancellation of 22 mRNA vaccine development projects totaling nearly $500 million, ending federal contracts with Pfizer, Sanofi, Emory University, and others [5]. Mike Osterholm, a University of Minnesota expert on infectious diseases, called it "the most dangerous decision in public health" in his 50 years in the field [6]. Rick Bright, a former head of the Biomedical Advanced Research and Development Authority (BARDA), warned it was "a huge strategic failure that will be measured in lives lost during times of crisis" [7].

Kennedy justified the cuts with claims that mRNA vaccines "fail to protect effectively" against COVID-19 — a statement that FactCheck.org determined to be false, noting that the mRNA shots saved millions of lives during the pandemic [8].

The Measles Reckoning

The domestic consequences arrived swiftly. In 2025, the United States recorded more than 2,200 measles cases across 45 states — the highest total since the 1990s [9]. More than 70 percent of cases were children. Ninety-three percent were unvaccinated. Eleven percent required hospitalization. Two school-aged children and one adult died [4].

By early 2026, the count had already surpassed 1,100 additional cases, with South Carolina serving as the epicenter with over 960 confirmed infections [10]. The sustained outbreaks put the country at risk of losing its globally recognized measles "elimination status" for the first time in decades [9].

Throughout the crisis, Kennedy maintained that "the decision to vaccinate is a personal one," while emphasizing treatment over prevention and claiming that vitamin A could "dramatically" reduce measles deaths [4] — a position that public health experts said dangerously mischaracterized the science.

"Does RFK Jr. care that babies will needlessly die under his vaccination policies?" asked a headline in The Hill, reflecting a growing chorus of criticism from pediatricians, epidemiologists, and state health officials [11].

The Global Shockwave: Gavi and the Thimerosal Ultimatum

If the domestic impact was severe, the international consequences may prove catastrophic. The United States had pledged $2.6 billion to Gavi, the Vaccine Alliance, for the 2026–2030 period — roughly 13 percent of the organization's budget. Kennedy terminated all of it [12].

But he did not simply withdraw funding. He imposed a condition: Gavi must remove thimerosal, a mercury-based preservative, from all its vaccines — or the U.S. would "withhold future new funding" [13]. The State Department confirmed that "President Trump has trusted Secretary Robert F. Kennedy Jr. to manage the U.S. Government's relationship with Gavi" [13].

Thimerosal has been one of Kennedy's longest-running targets. In 2014, he edited a book arguing for its immediate removal from vaccines. But the World Health Organization has repeatedly concluded that thimerosal in the small amounts used in multi-dose vaccine vials does not cause harm [14]. And in the developing world, thimerosal is not optional — it is what prevents contamination in vials serving multiple patients, a logistical necessity in regions without reliable cold-chain infrastructure.

About 14 percent of Gavi's portfolio consists of vaccines containing thimerosal, including the pentavalent vaccine protecting against five diseases, the DTP vaccine, and the hepatitis B vaccine [13]. Removing it would require reformulating vaccines, redesigning supply chains, and dramatically increasing costs — all while children continue to die from preventable diseases.

The Observer Research Foundation estimated that the U.S. funding cut could leave 75 million children unvaccinated and result in over 1.2 million deaths from preventable diseases [15].

A Pledging Summit in Crisis

In June 2025, Gavi convened its high-level pledging summit in Paris, seeking $11.9 billion to fund its next five-year strategy. The event raised more than $9 billion — a substantial sum, but $2.9 billion short of the target [16].

The European Union committed more than €2 billion. The Gates Foundation pledged $1.6 billion. India and Nigeria stepped up with notable contributions. A record number of new donors came forward [17]. But the absence of the United States — historically one of Gavi's founding and largest donors — cast a long shadow.

Kennedy used the occasion to attack Gavi's safety record, declaring the U.S. was halting support until the alliance could "re-earn" public trust [16]. The statement stunned diplomats and health officials who had spent two decades building a bipartisan consensus around global immunization that had spanned administrations from George W. Bush through Joe Biden.

The UK's simultaneous announcement that it would reduce development assistance from 0.5 percent to 0.3 percent of GDP compounded the shortfall [15].

PEPFAR and the HIV/AIDS Fallout

The damage extended beyond vaccines. When the Trump administration halted foreign assistance funds early in 2025, HIV-positive individuals who relied on U.S.-funded PEPFAR programs for life-saving antiretroviral medications immediately lost access to care [18]. On February 6, 2025, the State Department issued a moratorium excluding anyone other than pregnant and breastfeeding women from accessing PrEP — the pre-exposure prophylaxis drug that prevents HIV infection [18].

Congressional Democrats sounded alarms. Rep. Robert Garcia of California wrote to Kennedy demanding an explanation, asserting that the HHS Secretary had "a history of peddling misinformation" about HIV and calling the cuts "alarming and unprecedented" [18]. Modeling by global health researchers projected that ongoing PEPFAR disruptions could result in over 100,000 excess HIV-related deaths across sub-Saharan Africa in a single year, with 11 million additional infections and 3 million additional AIDS-related deaths by 2030 [18].

The Senate ultimately pushed back, restoring PEPFAR funding in a broader rescission package [19]. And in February 2026, Congress passed legislation fully funding health agencies and restoring many of Kennedy's cuts [20]. But the damage from months of disrupted care, suspended programs, and severed partnerships could not be legislated away.

The Global Disease Landscape

The wider picture is grim. In April 2025, WHO, UNICEF, and Gavi issued a joint warning: vaccine-preventable disease outbreaks were threatening years of progress [21]. In the prior 12 months, 138 countries had reported measles cases, with 61 experiencing large or disruptive outbreaks — the highest number in any 12-month period since 2019 [21].

Meningitis cases in Africa rose sharply, with more than 5,500 suspected cases and nearly 300 deaths in 22 countries in the first three months of 2025 alone [21]. Yellow fever was climbing across both Africa and the Americas. Nearly half of WHO's 108 country offices — most in low- and lower-middle-income nations — reported moderate to severe disruptions to vaccination campaigns and routine immunization due to reduced donor funding [15].

Multiple experts warned that 2025 could become the first year since global tracking began in which under-five mortality rises rather than falls [1] — a reversal of one of humanity's most hard-won public health achievements.

A Fractured Scientific Consensus

Kennedy's actions have not gone unchallenged. The American Academy of Pediatrics publicly criticized his policies — and subsequently had its HHS funding cut [22]. Harvard's T.H. Chan School of Public Health warned that Kennedy's moves "could have broad ramifications for public health" [23]. The Center for American Progress documented what it called a "systematic" undermining of vaccine science [4]. The University of Manchester published an analysis detailing how Kennedy was "systematically undermining vaccines around the world" [24].

Yet Kennedy retains support from some quarters. The Daily Signal argued that his skepticism of COVID-19 vaccines aligned with an emerging "international policy consensus" questioning pandemic-era mandates [25]. His allies frame his actions as overdue accountability for pharmaceutical conflicts of interest.

What Comes Next

The trajectory is uncertain. Congressional intervention has restored some funding, but the institutional damage — disbanded advisory committees, canceled research programs, severed international partnerships — is not easily reversed. Gavi faces a $2.9 billion gap. mRNA research that might have yielded universal flu or coronavirus vaccines has been abandoned. And the global immunization infrastructure that took decades to build is under strain from both funding cuts and the credibility crisis that Kennedy's rhetoric has fueled.

The question is no longer whether RFK Jr.'s policies will have global consequences. It is whether those consequences can be contained before they become irreversible — before elimination statuses are lost, before outbreaks become epidemics, and before the children who were never vaccinated become the statistics that prove what was at stake.